Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07088185

Pulmonary Outcomes on Patients With Lung Fibrosis

The pulmonary fibrosis is lung disease that occurs when lung tissue become damaged and scarred. The objectives of treatment are to improve symptoms and quality of life, and slow disease progression.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Conditions

Lung Fibrosis Fibrosis Lung Diseases Lung Diseases, Interstitial Pathologic Processes Pathological Conditions, Signs and Symptoms Pulmonary Fibrosis Respiratory Tract Diseases

Age range

35 year–55 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

South valley university

Qina, Egypt

About this study

This study will include 60 patients with pulmonary fibrosis from both gender who are aged from 35 - 55 years old.This study will be randomized controlled trial.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • both gender.
  • patients with cystic fibrosis.

Exclusion criteria

  • severe chronic disorders.
  • heart failure
  • respiratory failure.
  • age less than 35 or older than 55 years old.

Treatment and study plan

Routine medical care

Other

Routine medical care

Pulmonary Rehabilitation

Other

Pulmonary rehabilitation ( breathing exercises, posture drainage, additive techniques with postural drainage like vibration,shaking and percussion, active cycle of breathing techniques, autogenic drainage) plus routine care.

Primary outcomes

  1. FVC

    Time frame: One month

    Forced vital capacity (FVC).

  2. FEV1

    Time frame: One month

    Forced expiratory volume in the first second (FEV1)

  3. The FEV1 on FVC

    Time frame: One month.

    The ratio between FEV1 and FVC

Sponsors and collaborators

Lead sponsor

South Valley University

Other

Registry information

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Jul 28, 2025
Registry last updated
Jul 28, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.